Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Wrong...I cared and read the filings and it's going to be approved. Only needs Redman and Payne to approve and that's a given. No board of director approval needed. Authorized shares are going to be 950,000,000 soon (on or before this Thursday 9/28/17).
Sources:
DEF 14C dated 9/6/17
PRE 14C dated 8/22/17
Transparent lies and blatant mis-information on the website of a company that is supposed to be so forthcoming and honest is troubling.
Futhermore, he is no longer a "full-professor at Clemson University in South Carolina." as webpage states.
https://www.oncolixbio.com/advisors.html
Patent clarification. There has been a lot of posts boasting about the patents Oncolix has. THEY ARE NOT ONCOLIX PATENTS, THEY ARE WEN Y. CHEN'S PATENTS.
Webpage https://www.oncolixbio.com/our-patents.html is misleading everyone to believe the patents are their patents.
Now we know why Redman thanked AEPP investors during a conference call awhile back....what he would say now is "thank you AEPP investors for keeping the price from tanking while I sold my shares".....lol
Why would Redman sell shares at this stage of the game when he could have waited a little while longer for the highly anticipated ticker change????
Time for what??? Price drop to .001??? Dilution???
Wrong again...everybody and their brothers know about this stinky pinky. News has been everywhere.
Not asking you to buy my theory, just look at the current price...and no, people are not waiting for the ticker change, and no, this has not been flying under the radar, and no, and no, and no.
Any investor basing their investment or believing this is a legitimate play based on restricted shares is sadly mistaken.
LOL Reaper,
Call it what you want, but a spade is still a spade and dilution, large or small, will occur. The definition of what a reverse merger is and what occurs during a reverse merger is not at question here....I'm quite familiar and don't need someone to read to me like a 2nd grader.
The only reason Oncolix went the reverse merger route was because it was cheap and a fast route to the stock market, and I don't believe for one second that they intend to make it to NASDAQ.
Sole purpose of the merger was to create golden parachutes for their restless investors at the expense of naive, mis-informed, and greedy pinky stock investors.
This is not the beginning for Oncolix, it's a quick and cheap way to the end.
Dilution is inevitable..."The Board of Directors is considering, and will continue to consider, various financing options, including the issuance of Common Stock and Preferred Stock or securities convertible into Common Stock, from time to time to raise additional capital necessary to support future growth of the Company. As a result of the increase in authorized shares of Common Stock and Preferred Stock, the Board of Directors will have more flexibility to pursue opportunities to engage in possible future capital market transactions involving Common Stock, Preferred Stock or other securities convertible into Common Stock, including, without limitation, public offerings or private placements of such Common Stock or securities convertible into Common Stock."
Source:
https://www.sec.gov/Archives/edgar/data/1584137/000147793217004134/aepp_pre14c.htm
Outstanding post!!! Everything stated makes perfect sense
Bullish trend....lol. Been a bearish trend since the day this was posted. Such BS
In laraz I trust...been right so far about this POS and fake merger, and always dead on about predicting price drops
What a schmuck..he didn't get the name right...lol. Said "Advanced Engineering", supposed to be "Advanced Environmental"
More dilution......
Note 7 - Related-Party Transactions
As of December 31, 2016, GHC was the majority stockholder of Oncolix, and GHC is an affiliate of GHS. An affiliate of GHS is the site for clinical trial activities. Accounts payable to GHC and GHS for services approximated $61,935 and $22,911 at December 31, 2016 and 2015, respectively.
We have engaged a contract manufacturer and clinical research firms and certain of the costs incurred have been paid or will be paid through the issuance of capital stock.
Source: S-1 from 8/29/17
No PR will be able to hide the fact that major dilution is coming:
Shares to Register:
(1) Pursuant to Rule 416 under the Securities Act of 1933, the Registrant is also registering such additional indeterminate number of shares as may become necessary to adjust the number of shares as a result of a stock split, stock dividend or similar adjustment of its outstanding Common Stock. Registrant is also registering additional shares of Common Stock to be available for issuance based on market fluctuation.
(2) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended, based on the average high and low prices of the Common Stock as traded on the OTC Pink on August 24, 2017.
(3) Represents shares of Common Stock issuable by the registrant upon the conversion of the convertible notes in the aggregate original principal amount of $4,190,463 issued to the selling security holders (the “Convertible Notes”) pursuant to the terms of the Convertible Notes dated August 3, 2017.
(4) Represents shares of Common Stock issuable by the registrant upon the conversion of interest to be accrued pursuant to the terms of the Convertible Notes at a conversion price of $0.075 per share.
(5) Represents shares of Common Stock as a buffer in the event the monthly redemption payment or interest payment calculations are based on the lower of $0.075 per share and 75% of the average of the five lowest closing bid prices for the twenty consecutive trading days prior to such determination date.
(6) Represents shares of Common Stock issuable by the registrant upon exercise of Warrants to purchase shares of Common Stock to be issued to the selling security holders (the “Warrants”) upon the terms and conditions set forth in the warrant agreement dated August 3, 2017.
No dilution yet....but it's coming
Never dream about worthless penny stocks like AEPP so I'll never have a nightmare
Will always be a dream that never comes true...lol
Really....so those who sold at .10 on Monday are not getting in again at .05-.06???? lol
Totally agree!
Redman needs to pull a rabbit out of his hat to get this back to .10 or higher
Cheapies very abundant now...lol
Ya, there's some stuff in that S1 that shouts SELL NOW!!!!!
Let me guess...a base was created at .12, then a new base at .10, now a new base at .08??? lol
Complete and total bullshit!
No proof, no evidence, no link to where you got your info????????
Novartis already did the research with over 70 patients and had no success....wow!!! Did not know that....great find!
Must be looking at different stocks....don't see anything remotely close to 250,000 buys today....lol
We shall see, but I doubt it....about 250,000 was dumped this morning
Appears that some investors are tired of playing this waiting game....BIG sells today
Sadly mistaken if you think Prolanta will pass Phase I with only 3 patients......lol
Wrong....Phase I is not usually 3 people.....way off. It is 20-100.
https://www.fda.gov/forpatients/approvals/drugs/ucm405622.htm
Strange...volume last Friday was 607,712, the highest it's been for the past month, and then this week the price has been lower each day...so much for higher volume, higher price.